← back to search

Júlio Croda

Faculty (United Kingdom) · BR
Area of research
Infectious Diseases · Health
Research interest
Research interests include Tuberculosis Research and Epidemiology, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, and Vaccine Coverage and Hesitancy.
h-index
53
citations
11,450
works
341
NIH funding
primary concept
Medicine
email

Recent publications

Travel-associated international spread of Oropouche virus beyond the Amazon
Journal of Travel Medicine 2025cited by 16position: middledoi
Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study
The Lancet Infectious Diseases 2025cited by 8position: lastdoi
The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?
The Lancet Infectious Diseases 2025cited by 5position: middledoi
Rapid Viral Expansion Beyond the Amazon Basin: Increased Epidemic Activity of Oropouche Virus Across the Americas
medRxiv 2024cited by 19position: middledoi
Serial Mass Screening for Tuberculosis Among Incarcerated Persons in Brazil
Clinical Infectious Diseases 2024cited by 15position: lastdoi
Excess tuberculosis risk during and following incarceration in Paraguay: a retrospective cohort study
The Lancet Regional Health - Americas 2024cited by 13position: middledoi
Corrigendum: Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil
Frontiers in Public Health 2024cited by 0position: middledoi
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers
New England Journal of Medicine 2023cited by 116position: middledoi
Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysis
The Lancet Public Health 2023cited by 68position: middledoi
Scaling up evidence-based approaches to tuberculosis screening in prisons
The Lancet Public Health 2023cited by 34position: middledoi
Phylogeography and transmission of Mycobacterium tuberculosis spanning prisons and surrounding communities in Paraguay
Nature Communications 2023cited by 30position: middledoi
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
Science Translational Medicine 2023cited by 16position: middledoi
Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment
PLoS Medicine 2023cited by 12position: middledoi
Unveiling the Impact of the Omicron Variant: Insights from Genomic Surveillance in Mato Grosso do Sul, Midwest Brazil
Viruses 2023cited by 10position: middledoi
Dengue Fever Surveillance in Mato Grosso do Sul: Insights from Genomic Analysis and Implications for Public Health Strategies
Viruses 2023cited by 4position: middledoi
Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil
Frontiers in Public Health 2023cited by 1position: middledoi
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis
The Lancet Global Health 2022cited by 196position: middledoi
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Nature Communications 2022cited by 113position: lastdoi
Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil
Nature Microbiology 2022cited by 110position: middledoi
Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals
Nature Medicine 2022cited by 61position: middledoi
Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis
PLoS Medicine 2022cited by 17position: middledoi
Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons
Clinical Infectious Diseases 2021cited by 25position: lastdoi
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
Nature Human Behaviour 2020cited by 445position: middledoi
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
The Lancet 2020cited by 347position: middledoi
Genomic and Epidemiological Surveillance of Zika Virus in the Amazon Region
Cell Reports 2020cited by 78position: middledoi
Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies
The Lancet Respiratory Medicine 2019cited by 80position: middledoi
Detection, survival and infectious potential of<i>Mycobacterium tuberculosis</i>in the environment: a review of the evidence and epidemiological implications
European Respiratory Journal 2019cited by 62position: middledoi
Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting
Tuberculosis 2018cited by 16position: middledoi
Limonene reduces hyperalgesia induced by gp120 and cytokines by modulation of IL-1 β and protein expression in spinal cord of mice
Life Sciences 2016cited by 42position: middledoi
Antihyperalgesic and antidepressive actions of (R)-(+)-limonene, α-phellandrene, and essential oil from<i>Schinus terebinthifolius</i>fruits in a neuropathic pain model
Nutritional Neuroscience 2014cited by 88position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jason R. Andrews · Stanford University16 papers (2018–2025)Leonardo Martínez · Boston University6 papers (2019–2024) · 5 papers (2023–2024)C. Robert Horsburgh · Boston University4 papers (2018–2023) · 4 papers (2021–2025)Alberto L. García‐Basteiro · Barcelona Institute for Global Health4 papers (2023–2025)Katharine S. Walter · University of Utah3 papers (2019–2024) · 3 papers (2023–2024)Otávio T. Ranzani · London School of Hygiene & Tropical Medicine3 papers (2022–2025)Mark Hatherill · University of Cape Town3 papers (2018–2025)Matt D. T. Hitchings · University of Florida3 papers (2022–2025)Albert I. Ko · Yale University3 papers (2022–2025)Derek A. T. Cummings · University of Florida Health3 papers (2022–2025)Joilson Xavier · Università Campus Bio-Medico3 papers (2023–2024) · 3 papers (2023–2024)Salome Charalambous · London School of Hygiene & Tropical Medicine3 papers (2023–2025) · 3 papers (2021–2024)Guillermo Sequera · Universitat de Barcelona3 papers (2023–2024) · 3 papers (2023–2024) · 3 papers (2023–2024)